Thread: Treatment options
View Single Post
  #1  
Old Tue Apr 27, 2010, 04:34 AM
Birgitta-A Birgitta-A is offline
Member
  
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918
Treatment options
Hi all,
Here is a discussion about prescribing decisions for high-risk MDS. Emerging therapies are Gemtuzumab (Pfizer’s Mylotarg), Clofarabine (Genzyme’s Clolar/Clofarex/Evoltra) and Vorinostat (Merck & Co.’s Zolinza).

http://www.decisionresources.com/Pro...t?r=dbaspd3010
Kind regards
Birgitta-A
Reply With Quote